Compare XRX & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRX | KMDA |
|---|---|---|
| Founded | 1906 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.6M | 385.3M |
| IPO Year | N/A | N/A |
| Metric | XRX | KMDA |
|---|---|---|
| Price | $2.62 | $7.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.50 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 3.5M | 102.2K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.82% | 2.85% |
| EPS Growth | N/A | ★ 30.41 |
| EPS | N/A | ★ 0.35 |
| Revenue | ★ $6,607,000,000.00 | $174,787,000.00 |
| Revenue This Year | $12.39 | $14.90 |
| Revenue Next Year | $8.31 | $9.91 |
| P/E Ratio | ★ N/A | $19.76 |
| Revenue Growth | 3.67 | ★ 10.36 |
| 52 Week Low | $2.32 | $5.54 |
| 52 Week High | $9.91 | $9.16 |
| Indicator | XRX | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 53.92 |
| Support Level | $2.62 | $6.63 |
| Resistance Level | $2.74 | $7.07 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 52.43 | 66.19 |
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.